Tweet
We are looking for a highly motivated research technician or lab manager who wants to contribute to cutting-edge biomedical research with a focus on epigenetics, cancer, and whole genome medicine. Our lab is based at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna. It combines advanced technology (single-cell sequencing, drug screening, mass spectrometry, machine learning, etc.) with relevant biological models and access to patients.
The Candidate
We are looking for highly motivated, well-organized, and hard-working candidates who feel comfortable working in a highly dynamic and ambitious research environment. A typical candidate would have a Bachelor or Master degree in the life sciences and prior experience doing wet-lab work in a demanding environment. Candidates with a TA/MTA diploma or with a PhD will also be considered. Tasks and pay are commensurable with experience and skills. We take career development of our staff seriously at CeMM. For example, we will train the successful candidate in various state-of-the-art technologies that are in high demand in both aca-demia and industry, and we encourage substantial contribution and co-authorship for publications in top journals. We also expect to fill the more senior position of a lab manager within the next few years, thus providing the potential for career development within CeMM depending on interest and performance.
Typical Tasks
• Next generation sequencing. Preparing samples for genome, epigenome, and transcriptome map-ping
• Cell culture. Maintaining and manipulating cell lines and primary cells for biomedical research
• Gene targeting. Using CRISPR technology to create knockout cell lines
• Drug screening. Conducting epigenetic drug screens in collaboration with the chemical biology plat-form at CeMM
• Technology development. Working together with PhD students or postdocs to develop innovative epigenome technologies
• Lab management. Keeping track of lab resources and contributing to order management
• Training. Helping new staff and junior lab members to get started in the lab
The Lab (http://www.medical-epigenomics.org/)
The Medical Epigenomics Lab at CeMM combines large-scale epigenome analysis with stem cell biology and computational modeling, in order to better understand and treat cancer and other diseases. We focus broad-ly on the blood as the organ that connects all other organs, and we work closely with biologists and medical researchers at the Medical University of Vienna, aiming to advance personalized medicine through epige-nome sequencing and bioinformatic innovation. Specific research interests include (but are not limited to):
• Epigenomics. We perform large-scale epigenome mapping in order to dissect the dynamics of cancer development and emerging drug resistance. This work is closely connected with the BLUEPRINT pro-ject and the International Human Epigenome Consortium.
• Technology. Exciting biomedical research is often driven by new technologies. Our lab is therefore heavily invested into technology development, including single-cell protocols, nanopore sequencing, CRISPR, and epigenome editing.
• Bioinformatics. New algorithms and advanced computational methods allow us to accurately infer epigenetic cell states from large-scale datasets, in order to reconstruct the epigenetic landscape that controls cellular differentiation and reprogramming.
• Diagnostics. Using large-scale DNA methylation mapping, bioinformatic prioritization, and functional characterization, we strive to develop clinically relevant biomarkers for informing personalized cancer therapy.
The Principal Investigator (http://christoph-bock.org/)
Christoph Bock is an epigenome researcher and principal investigator at the CeMM Research Center for Mo-lecular Medicine of the Austrian Academy of Sciences. He is also a guest professor at the Medical University of Vienna's Department for Laboratory Medicine, the scientific coordinator of the Bio-medical Sequencing Facility at CeMM, and an adjunct group leader at the Max Planck Institute for Informatics in Germany. He has a background in bioinformatics and epigenomics (http://scholar.google.com/citations?user=9qSsTcIAAAAJ), with a PhD at the Max Planck Institute for Informatics (for which he received an Otto Hahn Medal by the Max Planck Society) and postdoctoral re-search at the Broad Institute and Harvard University (where he con-tributed to the Roadmap Epigenomics Project). Christoph joined CeMM in 2012, and he is a 2014 recipient of the New Frontier Group award of the Austrian Academy of Sciences. He leads Genom Austria (http://www.personalgenomes.org/austria), which is the Austrian Personal Genome Project; and he is a principal investigator in several EU projects, most notably for BLUEPRINT, which is the European contribution to the International Human Epigenome Consortium.
The Institute (http://www.cemm.at/)
The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and medical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation, and immune disorders. CeMM is located in a new building at the center of Vienna’s Medical University campus, within walking distance of Vienna’s historical city center. According to a study by “The Scientist”, CeMM is among the top-5 best places to work in academia world-wide (http://the-scientist.com/2012/08/01/...-academia-2012). Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, and more than 30 different nationalities are represented at the institute.
Please submit cover letter, curriculum vitae, academic transcripts and contact details of three referees to [email protected]. Reference Code: TA CBock. Applications will be reviewed on a rolling basis, and any application received by 31 March 2015 will be considered. Start dates are flexible.
Download PDF: http://data.medical-epigenomics.org/...c_Medicine.pdf
The Candidate
We are looking for highly motivated, well-organized, and hard-working candidates who feel comfortable working in a highly dynamic and ambitious research environment. A typical candidate would have a Bachelor or Master degree in the life sciences and prior experience doing wet-lab work in a demanding environment. Candidates with a TA/MTA diploma or with a PhD will also be considered. Tasks and pay are commensurable with experience and skills. We take career development of our staff seriously at CeMM. For example, we will train the successful candidate in various state-of-the-art technologies that are in high demand in both aca-demia and industry, and we encourage substantial contribution and co-authorship for publications in top journals. We also expect to fill the more senior position of a lab manager within the next few years, thus providing the potential for career development within CeMM depending on interest and performance.
Typical Tasks
• Next generation sequencing. Preparing samples for genome, epigenome, and transcriptome map-ping
• Cell culture. Maintaining and manipulating cell lines and primary cells for biomedical research
• Gene targeting. Using CRISPR technology to create knockout cell lines
• Drug screening. Conducting epigenetic drug screens in collaboration with the chemical biology plat-form at CeMM
• Technology development. Working together with PhD students or postdocs to develop innovative epigenome technologies
• Lab management. Keeping track of lab resources and contributing to order management
• Training. Helping new staff and junior lab members to get started in the lab
The Lab (http://www.medical-epigenomics.org/)
The Medical Epigenomics Lab at CeMM combines large-scale epigenome analysis with stem cell biology and computational modeling, in order to better understand and treat cancer and other diseases. We focus broad-ly on the blood as the organ that connects all other organs, and we work closely with biologists and medical researchers at the Medical University of Vienna, aiming to advance personalized medicine through epige-nome sequencing and bioinformatic innovation. Specific research interests include (but are not limited to):
• Epigenomics. We perform large-scale epigenome mapping in order to dissect the dynamics of cancer development and emerging drug resistance. This work is closely connected with the BLUEPRINT pro-ject and the International Human Epigenome Consortium.
• Technology. Exciting biomedical research is often driven by new technologies. Our lab is therefore heavily invested into technology development, including single-cell protocols, nanopore sequencing, CRISPR, and epigenome editing.
• Bioinformatics. New algorithms and advanced computational methods allow us to accurately infer epigenetic cell states from large-scale datasets, in order to reconstruct the epigenetic landscape that controls cellular differentiation and reprogramming.
• Diagnostics. Using large-scale DNA methylation mapping, bioinformatic prioritization, and functional characterization, we strive to develop clinically relevant biomarkers for informing personalized cancer therapy.
The Principal Investigator (http://christoph-bock.org/)
Christoph Bock is an epigenome researcher and principal investigator at the CeMM Research Center for Mo-lecular Medicine of the Austrian Academy of Sciences. He is also a guest professor at the Medical University of Vienna's Department for Laboratory Medicine, the scientific coordinator of the Bio-medical Sequencing Facility at CeMM, and an adjunct group leader at the Max Planck Institute for Informatics in Germany. He has a background in bioinformatics and epigenomics (http://scholar.google.com/citations?user=9qSsTcIAAAAJ), with a PhD at the Max Planck Institute for Informatics (for which he received an Otto Hahn Medal by the Max Planck Society) and postdoctoral re-search at the Broad Institute and Harvard University (where he con-tributed to the Roadmap Epigenomics Project). Christoph joined CeMM in 2012, and he is a 2014 recipient of the New Frontier Group award of the Austrian Academy of Sciences. He leads Genom Austria (http://www.personalgenomes.org/austria), which is the Austrian Personal Genome Project; and he is a principal investigator in several EU projects, most notably for BLUEPRINT, which is the European contribution to the International Human Epigenome Consortium.
The Institute (http://www.cemm.at/)
The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and medical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation, and immune disorders. CeMM is located in a new building at the center of Vienna’s Medical University campus, within walking distance of Vienna’s historical city center. According to a study by “The Scientist”, CeMM is among the top-5 best places to work in academia world-wide (http://the-scientist.com/2012/08/01/...-academia-2012). Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, and more than 30 different nationalities are represented at the institute.
Please submit cover letter, curriculum vitae, academic transcripts and contact details of three referees to [email protected]. Reference Code: TA CBock. Applications will be reviewed on a rolling basis, and any application received by 31 March 2015 will be considered. Start dates are flexible.
Download PDF: http://data.medical-epigenomics.org/...c_Medicine.pdf